BlackRock Institutional Trust’s La Jolla Pharmaceutical Company LJPC Stock Holding History

BlackRock Institutional Trust’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.34M	Buy	361,437 +104	+0%	+$1.99K	﹤0.01%	2633
2016 Q3	$8.6M	Buy	361,333 +13,689	+4%	+$258K	﹤0.01%	2424
2016 Q2	$5.56M	Buy	347,644 +10,900	+3%	+$196K	﹤0.01%	2625
2016 Q1	$7.04M	Buy	336,744 +1,890	+0.6%	+$33.7K	﹤0.01%	2490
2015 Q4	$9.04M	Buy	334,854 +20,763	+7%	+$566K	﹤0.01%	2388
2015 Q3	$8.73M	Buy	314,091 +102,520	+48%	+$3.23M	﹤0.01%	2382
2015 Q2	$5.19M	Buy	211,571 +86,643	+69%	+$1.79M	﹤0.01%	2753
2015 Q1	$2.29M	Buy	124,928 +80,719	+183%	+$1.64M	﹤0.01%	3055
2014 Q4	$816K	Buy	+44,209	New	+$525K	﹤0.01%	3395

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's LJPC Position: Q4 2016 in Review

BlackRock Institutional Trust increased its La Jolla Pharmaceutical Company (LJPC) stake by 0.03% in Q4 2016, buying an estimated $1.99K and bringing the position to 361,437 shares worth $6.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

BlackRock Institutional Trust first reported a position in LJPC in Q4 2014 and has held it in 9 quarters since. The position peaked at $9.04M in Q4 2015. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

BlackRock Institutional Trust held 361,437 shares of La Jolla Pharmaceutical Company worth $6.34M as of Q4 2016.
BlackRock Institutional Trust bought 104 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $1.99K.
La Jolla Pharmaceutical Company made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2633 holding.
BlackRock Institutional Trust first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and has held it in 9 quarters since.
BlackRock Institutional Trust's La Jolla Pharmaceutical Company position peaked at $9.04M in Q4 2015.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.